Trials / Completed
CompletedNCT04349800
A Single Dose Safety, Tolerability, Pharmacokinetic and Food Effect Study of KVD900 (Sebetralstat) in Healthy Volunteers
A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of KVD900 Followed by Crossover Sub-studies of KVD900 Formulations, and Food Effect in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 84 (actual)
- Sponsor
- KalVista Pharmaceuticals, Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A safety, tolerability, pharmacokinetic and food effect study of KVD900 in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KVD900 | Active |
| DRUG | Placebo to KVD900 | Placebo |
Timeline
- Start date
- 2018-01-04
- Primary completion
- 2018-09-10
- Completion
- 2018-09-10
- First posted
- 2020-04-16
- Last updated
- 2025-04-29
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT04349800. Inclusion in this directory is not an endorsement.